Trials / Completed
CompletedNCT06687759
A Study of Calderasib (MK-1084) Human Absorption, Distribution, Metabolism, and Excretion in Healthy Adult Participants (MK-1084-006)
A Phase 1 Study to Evaluate the Absorption, Distribution, Metabolism, and Excretion of [14C]MK-1084 in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to learn what happens to calderasib in a healthy person's body over time and how it is cleared from the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]Calderasib | Oral administration |
Timeline
- Start date
- 2024-06-26
- Primary completion
- 2024-08-07
- Completion
- 2024-08-07
- First posted
- 2024-11-14
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06687759. Inclusion in this directory is not an endorsement.